In the analysis with all breast cancer subtypes, we observed significant differences in the status of hormone receptors (RP, p <0.0001; RE, p <0.0001), HER2 (p <0.0001), and PAM50 classification (p <0.0001) for those three lncRNAs. The gene discussed is ERBB2; the disease is breast carcinoma.